| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001546A2 Polyketides and their synthesis |
| 01/15/1998 | WO1998001447A1 Pyridyl-piperazinyl-phenyl-oxazolidinone derivatives and their use as antibacterials |
| 01/15/1998 | WO1998001446A1 Substituted piperazinyl-phenyl-oxazolidinone derivatives and their use as anti-bacterial agents |
| 01/15/1998 | WO1998001445A1 Indole derivatives for the treatment of osteoporosis |
| 01/15/1998 | WO1998001154A2 Treatment and diagnosis of infections of gram positive cocci |
| 01/15/1998 | WO1998001150A1 Interleukin-8 as an antiviral and antitumor agent |
| 01/15/1998 | WO1998001144A1 Antiviral agents from plant extracts and use for treatment of viral infections |
| 01/15/1998 | WO1998001127A1 Veterinary use of a pleuromutilin derivative |
| 01/15/1998 | WO1997046673A3 Inhibition of hiv-1 replication by antisense rna expression |
| 01/15/1998 | WO1997040166A3 Simian-human hav having a chimeric 2c protein |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | CA2259965A1 Hiv envelope polypeptides and vaccine |
| 01/15/1998 | CA2259961A1 Protein and peptide vaccines for inducing mucosal immunity |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259463A1 Polyketides and their synthesis |
| 01/15/1998 | CA2258697A1 Interleukin-8 as an antiviral and antitumor agent |
| 01/14/1998 | EP0818442A2 Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor |
| 01/14/1998 | EP0818207A2 Medical article |
| 01/14/1998 | EP0818202A1 Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid |
| 01/14/1998 | EP0817864A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa |
| 01/14/1998 | EP0817860A1 Pseudotyped retroviral particles |
| 01/14/1998 | EP0817858A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 01/14/1998 | EP0817852A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
| 01/14/1998 | EP0817851A2 Dna encoding human papilloma virus type 18 |
| 01/14/1998 | EP0817845A1 Conditional expression system |
| 01/14/1998 | EP0817797A1 Glycopeptide antibiotic derivatives |
| 01/14/1998 | EP0817796A1 Cyclic peptide nuclei and derivatives thereof |
| 01/14/1998 | EP0817787A1 Nitrogenous macrocyclic compounds |
| 01/14/1998 | EP0817786A1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 01/14/1998 | EP0817769A1 Novel borneol esters, process for their preparation and their pharmaceutical use |
| 01/14/1998 | EP0817647A1 Treatment for verotoxin-producing escherichia coli |
| 01/14/1998 | EP0817644A1 Treatment of papillomavirus-associated lesions using interleukin-12 |
| 01/14/1998 | EP0817640A1 Epithelial adhesive lactobacilli |
| 01/14/1998 | EP0817637A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 01/14/1998 | EP0817635A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | EP0652890B1 Oligonucleotide alkylphosphonothioates |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | CN1170412A Suger modified nucleosides and their use for synthesis of oligonucleotides |
| 01/14/1998 | CN1170408A 2-carbamoyl-1, 4, 5, 6,-tetrahydropyrazines |
| 01/14/1998 | CN1170367A Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 01/14/1998 | CN1169993A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof |
| 01/14/1998 | CN1169865A Chinese medicine for scorofula |
| 01/14/1998 | CN1036996C Preparation of £1R-oxo-3S-thiolanylthio (thiocarbonyl)-thio|-2-azetidinones |
| 01/14/1998 | CN1036993C Method for preparation aromatase inhigiting 4(5)-imidazoles |
| 01/13/1998 | US5708169 5-amidomethyl α,β-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents |
| 01/13/1998 | US5708149 Method for producing purified recombinant Haemophilus influenzae transferrin binding proteins |
| 01/13/1998 | US5708145 Antibodies |
| 01/13/1998 | US5708023 Nonirritating gel for skin |
| 01/13/1998 | US5708000 N4-substituted cytosinyl 1,3-oxathiolane nucleoside analogues, and their antiviral activity |
| 01/13/1998 | US5707993 Biocides |
| 01/13/1998 | US5707992 Microbiocides, antitumor agents |
| 01/13/1998 | US5707987 Carbapenem derivatives |
| 01/13/1998 | US5707979 Inhibitors of retroviral protease inhibitors for treatment of hiv |
| 01/13/1998 | US5707977 Watersoluble azole antifungals |
| 01/13/1998 | US5707976 Substituted propane-2-OL derivatives |
| 01/13/1998 | US5707975 Itraconazole or saperconazole, hydroxypropyl-b-cyclodextrin solubilizer |
| 01/13/1998 | US5707864 Dna comprisinf nucleic acid encoding of mutant htlv matrix |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient |
| 01/13/1998 | US5707626 Methods of treating HIV infection using antibodies to the U2 small nuclear ribonuclear protein |
| 01/13/1998 | US5707615 Method of treating HIV infections with anti-viral formulations |
| 01/12/1998 | CA2210056A1 Cyclic sulfone derivatives |
| 01/08/1998 | WO1998000531A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | WO1998000439A2 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/08/1998 | WO1998000173A2 Targeted drug delivery using sulfonamide derivatives |
| 01/08/1998 | WO1998000167A1 Multivalent dtp-polio vaccines |
| 01/08/1998 | WO1998000166A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 01/08/1998 | WO1998000165A1 Porcine reproductive and respiratory syndrome vaccine |
| 01/08/1998 | WO1998000153A1 Amides |
| 01/08/1998 | WO1998000150A1 Pharmaceutical composition, comprising complement proteins, for the treatment of helicobacter infections and a method for the preparation of the composition |
| 01/08/1998 | WO1998000146A1 Water miscible erythromycin solutions |
| 01/08/1998 | WO1998000136A1 Virginiamycin mixture |
| 01/08/1998 | WO1998000135A1 Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
| 01/08/1998 | WO1998000116A1 Oral composition comprising a triazole antifungal compound |
| 01/08/1998 | WO1998000113A1 Solid solution of an antifungal agent with enhanced bioavailability |
| 01/08/1998 | WO1998000025A1 Aquatic animal treatment method and composition containing cajeput oil |
| 01/08/1998 | WO1997046255A3 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 01/08/1998 | WO1997034566A3 Electrophilic ketones for the treatment of herpesvirus infections |
| 01/08/1998 | DE19624154A1 Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung Ring Anne lined dihydropyrans, methods of preparation and their use |
| 01/08/1998 | CA2259415A1 Multivalent dtp-polio vaccines |
| 01/08/1998 | CA2259298A1 Virginiamycin mixture |
| 01/08/1998 | CA2258286A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | CA2258038A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/07/1998 | EP0816506A1 System for the expression of heterologous antigens as fusion proteins |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816379A2 DNA binding oligomers |
| 01/07/1998 | EP0816378A1 Glycopeptide antibiotic amide derivatives |
| 01/07/1998 | EP0816357A1 Substituted indazole derivatives |
| 01/07/1998 | EP0816344A1 Process for the production of 2,5-diamino-4,6-dichloropyrimidine |
| 01/07/1998 | EP0815856A2 Retroviral protease inhibitors |
| 01/07/1998 | EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815236A1 Haemophilus adhesion proteins |
| 01/07/1998 | EP0815235A1 Vaccines for plague |
| 01/07/1998 | EP0815234A1 Proteinase k resistant surface protein of neisseria meningitidis |
| 01/07/1998 | EP0815231A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 01/07/1998 | EP0815228A2 Cellubrevin homologs |